The Lancet Oncology in conversation with
A podcast by The Lancet Group
207 Episodes
-
Peptide receptor radionuclide therapy for neuroendocrine tumours
Published: 9/5/2020 -
Larotrectinib in patients with TRK fusion-positive solid tumours
Published: 4/7/2020 -
The future of radiotheranostics
Published: 3/11/2020 -
International standards for the analysis of patient-reported outcomes in cancer trials
Published: 3/3/2020 -
Presenting symptoms of cancer and stage at diagnosis
Published: 1/9/2020 -
Global public and philanthropic investment in childhood cancer research
Published: 12/4/2019 -
Cervical cancer in India
Published: 10/30/2019 -
Oropharyngeal squamous cell carcinoma
Published: 10/3/2019 -
Cancer in small island nations
Published: 9/3/2019 -
Advances in radioimmunotherapy
Published: 8/29/2019 -
International Neoadjuvant Melanoma Consortium
Published: 7/2/2019 -
IMWG consensus on imaging in plasma cell disorders
Published: 5/29/2019 -
Digital oncology
Published: 5/16/2019 -
Choosing Wisely India
Published: 4/2/2019 -
Paediatric vertebral radiotherapy
Published: 3/5/2019 -
Malignant plural mesothelioma
Published: 2/2/2019 -
CAR T-cell therapy
Published: 1/3/2019 -
Cervical cancer screening in older women
Published: 11/29/2018 -
Palliative care in oncology
Published: 10/19/2018 -
Global review of cancer control
Published: 9/27/2018
Editors at The Lancet Oncology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from early-stage breast cancer treatment to mRNA vaccines, the access to essential cancer medicines for children to measuring ovarian toxicity, and more.